Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : BRLI-- A substantially undervalued micro-cap -- Ignore unavailable to you. Want to Upgrade?

To: Tom Shutters who wrote (31)	3/20/1998 3:39:00 PM
From: Tom Shutters	Read Replies (1) \| Respond to of 105

From the 10-Q A factor that could cause a big increase in earnings in the second quarter as compared to the first quarter. "On September 30, 1997, the Company entered into an agreement to sell certain customer lists, its"GenCare" trade name and rights under two GenCare contracts to another laboratory for $4,600,000 in cash and $1,400,000 payable in four equal installments every six months beginning April 1, 1998, provided however that certain target revenues are reached. If target revenues are not reached amounts payable under the contract will be decreased up to a maximum of $700,000." Will that translate into .10+ next quarter and .20+ for the year? Any comments? Tom